Synthesis and biological activity of ester derivatives of mycophenolic acid and acridines/acridones as potential immunosuppressive agents

References

• Bentley R. Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant. Chem Rev 2000;100:3801–25
   PubMed Web of Science ®Google Scholar
• Cholewinski G, Malachowska-Ugarte M, Dzierzbicka K. The chemistry of mycophenolic acid – synthesis and modifications towards desired biological activity. Curr Med Chem 2010;17:1926–41
   PubMed Web of Science ®Google Scholar
• Papageorgiou, C. Enterohepatic recirculation: a powerful incentive for drug discovery in the inosine monophosphate dehydrogenase field. Mini-Rev Med Chem 2001;1:71–7
   PubMedGoogle Scholar
• Hedstrom L. IMP dehydrogenase: structure, mechanism and inhibition. Chem Rev 2009;109:2903–28
   PubMed Web of Science ®Google Scholar
• Sintchak MD, Nimmesgern E. The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmocol 2000;47:163–84
   PubMed Web of Science ®Google Scholar
• Kaufmann DB, Shapiro R, Lucey MR, et al. Immunosuppression: practice and trends. Am J Transplant 2004;4:38–53
   PubMed Web of Science ®Google Scholar
• Yang N, Wang J, Wang Z-W, et al. Computional insights into the inhibition of inosine 5′-monophosphate dehydrogenase by mycophenolic acid analogs: three dimensional quantitative structure-activity relationship and molecular docking studies. Chem Biol Drug Des 2012;79:1063–71
   PubMed Web of Science ®Google Scholar
• Kamar N, Oufroukhi L, Faure P, et al. Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium. Nephrol Dial Transplant 2005;20:2231–6
   PubMed Web of Science ®Google Scholar
• Aptaramanov B, Seyahi N, Alagoz S, et al. A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment. Transplant Proc 2011;43:833–6
   PubMed Web of Science ®Google Scholar
• Silva HT Jr, Yang HC, Abouljoud M, et al. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant 2007;7:595–608
   PubMed Web of Science ®Google Scholar
• Felczak K, Chen L, Wilson D, et al. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain. Bioorg Med Chem 2011;19:1594–605
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Takenaka J, Iwamori K, et al. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives. Bioorg Med Chem Lett 2010;18:8106–11
   Web of Science ®Google Scholar
• Habib E, León F, Bauer JD, et al. Mycophenolic derivatives from Eupenicillium parvum. J Nat Prod 2008;71:1915–18
   PubMed Web of Science ®Google Scholar
• Nelson PH, Carr SF, Devens BH, et al. Structure-activity relationships for inhibition of inosine monophosphatedehydrogenase by nuclear variants of mycophenolic acid. J Med Chem 1996;39:4181–96
   PubMed Web of Science ®Google Scholar
• Chen Z, Zheng Z, Huang H, et al. Penicacids A–C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07. Bioorg Med Chem Lett 2012;22:3332–5
   PubMed Web of Science ®Google Scholar
• Iwaszkiewicz-Grzes D, Cholewinski G, Kot-Wasik A, et al. Synthesis and biological activity of mycophenolic acid-amino acid derivatives. Eur J Med Chem 2013;69:863–71
   PubMed Web of Science ®Google Scholar
• Malachowska-Ugarte M, Cholewinski G, Chojnacki J, Dzierzbicka K. 4-[(tert-Butyldimethylsilyl)oxy]-6-methoxy-7-methyl-5-(oxiran-2-ylmethyl)-2-benzofuran-3(1H)-one. Acta Crystallogr E 2011;67:o3393
   Google Scholar
• Watkins WJ, Chen JM, Cho A, et al. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH. Bioorg Med Chem Lett 2006;16:3479–83
   PubMed Web of Science ®Google Scholar
• Fardis M, Mertzman M, Thomas W, et al. Use of benzofuran for concomitant protection of aldehyde and phenol groups in the preparation of mycophenolic acid analogues. J Org Chem 2006;71:4835–9
   PubMed Web of Science ®Google Scholar
• Chen L, Wilson D, Jayaram HN, Pankiewicz KW. Dual inhibitors of IMP-dehydrogenase and histone deacetylases for cancer treatment. J Med Chem 2007;50:6685–91
   PubMed Web of Science ®Google Scholar
• Rohloff JC, Gardner JO, Towne RW. Mycophenolate dianions. Tetrahedron Lett 1995;43:7803–6
   Web of Science ®Google Scholar
• Smith DB, Waltos AM, Loughhead DG, et al. Asymmetric synthesis and stereochemical assignment of RS-97613, a potent immunosuppressive and antiinflammatory agent. J Org Chem 1996;61:2236–41
   Web of Science ®Google Scholar
• Jones DF, Moore RH, Crawley GC. Microbial modifications of mycophenolic acid. J Chem Soc 1970;1725–1737
   Web of Science ®Google Scholar
• Jones DF, Mills SD. Preparation and antitumor properties of analogs and derivatives of mycophenolic acid. J Med Chem 1971;14:305–11
   PubMed Web of Science ®Google Scholar
• Suzuki S, Takaku S, Mori T. Antitumor activity of derivatives of mycophenolic acid. J Antibiotics 1976;3:275–85
   Web of Science ®Google Scholar
• Sunohara K, Mitsuhashi S, Shigetomi K, Ubukata M. Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH. Bioorg Med Chem Lett 2013;23:5140–4
   PubMed Web of Science ®Google Scholar
• Felczak K, Vince R, Pankiewicz KW. NAD-based inhibitors with anticancer potential. Bioorg Med Chem Lett 2014;24:332–6
   PubMed Web of Science ®Google Scholar
• Petrelli R, Vita P, Torquati I, et al. Novel inhibitors of inosine monophospate dehydrogenase in patent literature of the last decade. Recent Pat Anticancer Drug Discov 2013;8:103–25
   PubMed Web of Science ®Google Scholar
• Cholewinski G, Iwaszkiewicz Grzes D, Prejs M, et al. Synthesis of the inosine 5′-monophosphate dehydrogenase (IMPDH) inhibitors. J Enzyme Inhib Med Chem 2015;30:550–63
   PubMed Web of Science ®Google Scholar
• Cholewinski G, Dzierzbicka K, Kolodziejczyk AM. Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. Pharmacol Rep 2011;63:305–36
   PubMed Web of Science ®Google Scholar
• Denny WA. Acridine derivatives as chemotherapeutic agents. Curr Med Chem 2002;9:1655–65
   PubMed Web of Science ®Google Scholar
• Dzierzbicka K, Gozdowska, M, Wysocka-Skrzela B, Kołodziejczyk AM. Synthesis and anticancer activites of new MDP conjugates with amino-acridine/acridone derivatives. Drug Res 1999;56:20–4
   Google Scholar
• Dzierzbicka K, Kołodziejczyk AM, Wysocka-Skrzela B, Kołodziejczyk AS. Synthesis of muramyl dipeptide conjugated with acridine derivatives, showing anti-HIV-1 and anticancer activity. Polish J Chem 1994;68:37–45
   Google Scholar
• Dzierzbicka K, Kołodziejczyk AM, Wysocka-Skrzela B, et al. Synthesis and antitumor activity of conjugates of muramyldipeptides, normuramyldipeptide, and desmuramylpeptides with acridine/acridone derivatives. J Med Chem 2001;44:3606–15
   PubMed Web of Science ®Google Scholar
• Dzierzbicka K, Kołodziejczyk AM. Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine/acridone derivatives. J Med Chem 2003:46:183–9
   PubMed Web of Science ®Google Scholar
• Kukowska-Kaszuba M, Dzierzbicka K, Serocki M, Skladanowski A. Solid phase synthesis and biological activity of tuftsin conjugates. J Med Chem 2011;54:2447–54
   PubMed Web of Science ®Google Scholar
• Hess FK, Steward PB. Preparation of a new immunosuppressant 4,5-bis(aminomethyl)acridine. J Med Chem 1975;18:320–1
   PubMed Web of Science ®Google Scholar
• Wu H, Pagadala J, Yates ChR, et al. Synthesis and characterization of an anti-apoptotic immunosuppressive compound for improving the outcome of islet transplantation. Bioconjugate Chem 2013;24:2036–44
   PubMed Web of Science ®Google Scholar
• Dzierzbicka K, Kolodziejczyk AM. Adjuvants-essential components of new generation vaccines. Post Bioch 2006;52:204–11
   PubMedGoogle Scholar
• Wardowska A, Dzierzbicka K, Mysliwski A. Tuftsin-new analogues and properties. Post Bioch 2007;53:60–5
   PubMedGoogle Scholar
• Malachowska-Ugarte M, Cholewinski G, Dzierzbicka K, Trzonkowski P. Synthesis and biological activity of novel mycophenolic acid conjugates containing nitro-acridine/acridone derivatives. Eur J Med Chem 2012;54:197–201
   PubMed Web of Science ®Google Scholar
• Inanaga J, Hirata K, Saeki H, et al. A rapid esterification by means of mixed anhydride and its application to large-ring lactonization. Bull Chem Soc Jpn 1979;52:1989–93
   Web of Science ®Google Scholar
• Dhimitruka I, SantaLucia J Jr. Investigation of the Yamaguchi esterification mechanism. Synthesis of the Lux-S enzyme inhibitor using an improved esterification method. Org Lett 2006;8:47–50
   PubMed Web of Science ®Google Scholar
• Crouch RD. Selective monodeprotection of bis-silyl ethers. Tetrahedron 2004;60:5833–71
   Web of Science ®Google Scholar